Keystone Financial Group Emergent Bio Solutions Inc. Transaction History
Keystone Financial Group
- $1.07 Billion
- Q2 2025
A detailed history of Keystone Financial Group transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Keystone Financial Group holds 30,325 shares of EBS stock, worth $298,094. This represents 0.02% of its overall portfolio holdings.
Number of Shares
30,325
Previous 18,725
61.95%
Holding current value
$298,094
Previous $91,000
112.09%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding EBS
# of Institutions
192Shares Held
39.4MCall Options Held
299KPut Options Held
157K-
Black Rock Inc. New York, NY3.84MShares$37.7 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$35.5 Million2.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.58MShares$35.2 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.29MShares$22.5 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.85MShares$18.2 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $490M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...